No Data
No Data
Centessa Pharmaceuticals Updates on OX2R Agonist Pipeline
Press Release: Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer
TD Cowen Initiates Centessa Pharmaceuticals ADR at Buy
TD Cowen Initiates Centessa Pharmaceuticals(CNTA.US) With Buy Rating
A Look At The Fair Value Of Centessa Pharmaceuticals Plc (NASDAQ:CNTA)
Centessa Pharmaceuticals: Promising Market Position and Growth Potential in Orexin Agonists for Narcolepsy